You are here

Pfizer

Pfizer booster likely to be OK’d by Sept. 20, but Moderna’s may lag, Fauci says

Marketwatch

Mon, 09/6/21 - 08:59 pm

Moderna Therapeutics

Did the FDA Move Too Slowly in Fully Approving the Pfizer-BioNTech Vaccine?

Motley Fool

Mon, 09/6/21 - 06:38 pm

Here's the Biotech Pfizer Should Consider Acquiring Next

Motley Fool

Fri, 09/3/21 - 11:00 am

Trillium Therapeutics

Pfizer booster may lower COVID-19 risk 11-fold, early research suggests

Beckers Hospital Review

Thu, 09/2/21 - 10:13 pm

Pfizer, marking fast research pace, starts key trial of RSV vaccine

BioPharma Dive

Thu, 09/2/21 - 09:59 pm

clinical trials

AbbVie's stock and next megablockbuster take hits following new JAK warnings from FDA

Endpoints

Wed, 09/1/21 - 11:16 pm

FDA convenes adcomm for Pfizer COVID booster

RAPS.org

Wed, 09/1/21 - 11:00 pm

advisory panels

Pfizer, Merck launch large new trials of oral COVID-19 drugs

BioPharma Dive

Wed, 09/1/21 - 01:30 pm

clinical trials

Top FDA vaccine officials to leave agency as decision on COVID-19 boosters looms

Biopharma Reporter

Tue, 08/31/21 - 12:51 pm

FDA approval of Pfizer's COVID-19 vaccine spurs American confidence: Harris Poll

Fierce Pharma

Tue, 08/31/21 - 12:39 pm

consumer confidence

The sellside’s most controversial products

EP Vantage

Tue, 08/31/21 - 10:54 am

Vir Biotechnology

Moderna's Vaccine Is Said to Create More Antibodies Than Pfizer's

TheStreet.com

Tue, 08/31/21 - 10:51 am

Moderna Therapeutics

U.S. vaccine advisers unanimously favor Pfizer/BioNTech shot after approval

Yahoo/Reuters

Mon, 08/30/21 - 11:43 pm

Pfizer's abrocitinib beats blockbuster Dupixent in phase 3 eczema trial, but key questions remain

Fierce Biotech

Mon, 08/30/21 - 11:03 am

atopic dermatitis

clinical trials

Inside Pfizer’s labs, ‘variant hunters’ race to stay ahead of the pandemic’s next twist

Stat

Mon, 08/30/21 - 10:38 am

COVID-19 variants

Heart Problem More Common After Covid-19 Than After Vaccination, Study Finds

NY Times, NY

Thu, 08/26/21 - 01:26 pm

Did Pfizer's and BioNTech's FDA Submission Boost the Case for Booster Doses for All Americans?

Motley Fool

Thu, 08/26/21 - 10:58 am

Pfizer COVID-19 shot efficacy wanes over time in large UK study

Beckers Hospital Review

Wed, 08/25/21 - 09:25 pm

Johnson & Johnson touts antibody response for COVID-19 booster 8 months after original vaccination

Fierce Pharma

Wed, 08/25/21 - 12:14 pm

Moderna Therapeutics

Merck's 15-strain flu shot matches Prevnar 13 in late-stage infant study, but Pfizer's next-gen shot looms

Endpoints

Wed, 08/25/21 - 11:16 am

clinical trials

Pages